Actions and Detail Panel
Industry Intersect- Advancing Precision Medicine
Wed, March 29, 2017, 9:00 AM – 1:30 PM EDT
This three-part briefing will highlight how industry can work together and with the government to advance precision medicine and ensure patients get the right medicine at the right time.
Panel 1 (9:30-10:30am) – Breaking down Data Silos and Empowering Patients
Summary: No single hospital or institution will ever have enough patient genomic data to support evidence-based precision medicine. For example, all of the nation’s cancer institutions combined care for only 15% of the cancer population. Data must be shared across institutions in order to move the research forward and deliver high quality care to patients. Unfortunately, there is no standard platform or known ecosystem that has emerged to accomplish this goal. In this session, you will hear from industry leaders who have direct experience in the world of genomic data sharing and data aggregation. Panelists will discuss the current challenges behind data sharing efforts and what policymakers can do to break down data silos.
- Alice Borrelli, Director Global Health and Workforce Policy, Intel, Moderator
- Michael Matthews, President & Chairman, The Sequoia Project
- Mark Savage, Director of Health Information Technology Policy & Programs, National Partnership for Women and Families
- Tania Simoncelli, Senior Advisor to the Director and Executive Director, Count Me In Initiative, The Broad Institute of MIT and Harvard
- John Sotos, MD, Chief Medical Officer, Intel
Panel 2 (10:45-11:45am)– Making Cures More Personal- Modernizing Clinical Trials
Summary: Though the use of data is an integral part in advancing efforts to deliver cures to the public, challenges and limitations still exist that impede the clinical trial process for targeted therapies. Recent legislative and regulatory changes, including the 21st Century Cures Act and changes to the Common Rule, have sought to modernize the clinical trial process by leveraging new approaches. This panel will discuss how policy makers should build off of these advancements to fundamentally transform how patients engage in clinical trials to deliver on the promise of precision medicine.
- Bridget Walsh, Vice President, Federal Government Relations,Pfizer, Moderator
- Sean Khozin, MD, Senior Medical Officer, Office of Hematology and Oncology Products, FDA
- Craig Lipset, Head of Clinical Innovation, Pfizer
- Janet Marchibroda, Director of Innovation, Bipartisan Policy Center
- Daryl Pritchard, PhD, Vice President of Science Policy, Personalized Medicine Coalition
Panel 3 (12:00-1:00pm)– Innovating Care Delivery Models
Summary: From bench to bedside, technology continues to transform what defines “healthcare”. Unfortunately, federal health programs are not keeping pace with this rapid movement. New patient oriented models of care delivery are occurring across the US. Many modern and cost effective approaches are hindered by lagging reimbursement methods and regulatory hurdles. The panel will discuss novel approaches to care delivery using real-time data capture and machine learning and discuss how to accelerate the evolution of patient centric care models that will cut waste out of the system.
- Joel White, Senior Advisor, Health IT Now, Moderator
- Henry DePhillips, MD, Chief Medical Officer, Teladoc
- Ray Dorsey, MD, David M. Levy Professor of Neurology and Director of the CHET at the University of Rochester Medical Center
- Summer Kahlon, MD, Director, Care Innovation, Oracle Health Sciences
- Teresa Zayas Caban, PhD, Acting Chief of Staff & Chief Scientist, ONC